醋酸钙与碳酸钙治疗血液透析患者的效果分析

Effect Analysis of Calcium Acetate and Calcium Carbonate in the Treatment of Hemodialysis Patients

目的探究将醋酸钙与碳酸钙应用于血液透析钙磷代谢紊乱患者的治疗中的效果,评价其预后影响。方法在本院中选择时间段2016年12月—2018年12月间收入的所有血液透析患者钙磷代谢紊乱患者的一般资料,按照本次实验要求选择其中76例患者纳入研究开展实验,通过随机分组法将其分为两组,分别命名为对照组(n=38)与试验组(n=38)。对照组患者采用碳酸钙进行治疗,而试验组患者则采用醋酸钙进行治疗,对比两组患者的治疗效果,分析两组患者的血磷和血钙数据,评价其预后恢复。结果实验结果显示,试验组患者的钙磷代谢紊乱治愈率数据为89.47%(34/38),同时对照组患者钙磷代谢紊乱治愈率数据为63.16%(24/38),数据差异具有统计学意义(P<0.05)。并且实验结果显示,试验组患者的各项临床指标较对照组来说明显更优,数据对比差异具有统计学意义(P<0.05)。结论将醋酸钙与碳酸钙应用于血液透析钙磷代谢紊乱患者的治疗中,能够有效提高患者的治疗效果,有助于改善患者的各项临床指标,促进血液透析治疗工作的顺利开展,具有良好的应用价值。

Objective To investigate the effect of calcium acetate and calcium carbonate in the treatment of patients with disordered calcium and phosphorus metabolism in hemodialysis,and to evaluate its prognostic impact.Methods In our hospital,we selected the general data of patients with calcium and phosphorus metabolic disorders in all hemodialysis patients from December 2016 to December 2018.According to the requirements of this experiment,76 patients were included in the study and passed the experiment.They were divided into two groups by random grouping and named as control group(n=38)and experimental group(n=38).Patients in the control group were treated with calcium carbonate,while patients in the experimental group were treated with calcium acetate.The therapeutic effects of the two groups were compared.The blood phosphorus and blood calcium data of the two groups were analyzed to evaluate the prognosis.Results The experimental results showed that the cure rate of calcium and phosphorus metabolism disorder in the experimental group was 89.47%(34/38),and the cure rate of calcium and phosphorus metabolism disorder in the control group was 63.16%(24/38).Academic significance(P<0.05).And the experimental results showed that the clinical indexes of the experimental group were significantly better than the control group,and the data were significantly different(P<0.05).Conclusion Calcium acetate and calcium carbonate can be used in the treatment of patients with disordered calcium and phosphorus metabolism in hemodialysis,which can effectively improve the therapeutic effect of patients,help to improve various clinical indicators of patients,and promote the smooth development of hemodialysis treatment.